Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
about
A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infectionsChitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.Design, characterization, and in vitro evaluation of antifungal polymeric filmsChitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanismsComparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.Mucoadhesive bilayer tablets of propranolol hydrochloride.Marine polysaccharides in pharmaceutical applications: an overviewProtein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Effect of chitosan-ethylenediamine tetraacetic acid on Enterococcus faecalis dentinal biofilm and smear layer removal.Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: a technical noteFormulation and development of floating capsules of celecoxib: in vitro and in vivo evaluationPreparation and evaluation of a novel buccal adhesive systemDevelopment of Osmotically Controlled Mucoadhesive Cup-Core (OCMC) Tablet for The Anti-Inflammatory Activity.Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections.Vaginal Mucosa and Drug Delivery
P2860
Q30369008-D46842C2-0C9E-4704-8BC4-72BF5DAF684DQ36096590-82F2313F-BE36-416E-AC75-EB4FE4D22D9BQ36636474-313C0E12-9C22-40F6-8D3D-3C3A25836A85Q37360605-27D5BB47-7009-4C0D-BA94-8701FB94504FQ37360765-9CBAF065-C236-4D7F-A962-B9C1782B4BB9Q37360864-59BB2B6C-BBDF-401A-A588-77708313855AQ37800376-24032A20-84E6-4000-80A4-5FA7AADE50B5Q38260862-DD088B2F-4281-44F2-861F-300E923AE80AQ40531415-AD8C3B3F-634B-4A70-BBC9-B197ACFF35CAQ41970651-20EAEDD8-0459-4321-AFC8-4718D6770E44Q41989907-9105CAE2-154B-4347-98C1-EEA2B1D9CF33Q41990375-9AF2276E-6BB5-4837-ABF4-3A3C3A47735CQ42781912-398F5830-13EE-4286-82EF-519F3C765FC1Q42852118-71629A6E-0CBD-44A1-8187-677F4961674EQ57570821-B90BCE20-215B-4839-860C-EF286BF0C874
P2860
Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucoadhesive vaginal tablets a ...... timicrobial drug, acriflavine.
@en
Mucoadhesive vaginal tablets a ...... timicrobial drug, acriflavine.
@nl
type
label
Mucoadhesive vaginal tablets a ...... timicrobial drug, acriflavine.
@en
Mucoadhesive vaginal tablets a ...... timicrobial drug, acriflavine.
@nl
prefLabel
Mucoadhesive vaginal tablets a ...... timicrobial drug, acriflavine.
@en
Mucoadhesive vaginal tablets a ...... timicrobial drug, acriflavine.
@nl
P2093
P2860
P356
P1433
P1476
Mucoadhesive vaginal tablets a ...... timicrobial drug, acriflavine.
@en
P2093
Claudia Juliano
Elisabetta Gavini
Maria Cristina Bonferoni
Paolo Giunchedi
Vanna Sanna
P2860
P2888
P356
10.1208/PT030320
P407
P577
2002-01-01T00:00:00Z
P5875
P6179
1064225335